Search results
Results From The WOW.Com Content Network
Increases gastric emptying and small bowel motility Neuropeptide Y: Enteric nerves: Regulation of intestinal blood flow Neurotensin: Ileum: Affects gut motility; increases jejunal and ileal fluid secretion Pancreatic polypeptide: Pancreas: Inhibits pancreatic and biliary secretion Peptide YY: Colon: Inhibits food intake Somatostatin: Stomach ...
Its role in the intestine is to greatly stimulate secretion of water and electrolytes, [12] as well as relaxation of enteric smooth muscle, dilating peripheral blood vessels, stimulating pancreatic bicarbonate secretion, and inhibiting gastrin-stimulated gastric acid secretion. These effects work together to increase motility. [13]
One of the actions of GLP-1 is to inhibit gastric emptying, thus slowing down its own secretion upon postprandial activation. [1] [2] Fasting plasma concentration of biologically active GLP-1 range between 0 and 15 pmol/L in humans and is increased 2- to 3-fold upon food consumption depending on meal size and nutrient composition.
It can also be stimulated by a pH of 3-4 in the duodenum and by a pH of 1.5 in the stomach. Upon initiation of the reflex, the release of gastrin by G-cells in the antrum of the stomach is shut off. This in turn inhibits gastric motility and the secretion of gastric acid . [1]
An enterogastrone is any hormone secreted by the mucosa of the duodenum in the lower gastrointestinal tract in response to dietary lipids that inhibits the caudal (or "forward, analward") motion of the contents of chyme. The function of enterogastrone is almost the same as gastric inhibitor peptide, it inhibits gastric secretion and motility of ...
Effects on endocrine secretion Effects on exocrine secretion Effects on motility Other effects Stimulus for release; Gastrin: G Cells in stomach ECL cells; parietal cells None Increases acid secretion, increases mucus growth Stimulates gastric contraction None Peptides and amino acids in lumen; gastrin releasing peptide and ACh in nervous reflexes
Conversely, inhibition of CCK B receptors in the gut produces similar inhibition of secretion of gastric acid and pepsinogen enzymes as is seen with inhibition of CCK A receptors, [6] suggesting that while the CCK A and CCK B receptors comprise two structurally distinct families which bind different ligands and are primarily expressed in ...
In the stomach and intestines, a reduction in digestive activity. This results from a generally inhibitory effect of norepinephrine on the enteric nervous system, causing decreases in gastrointestinal mobility, blood flow, and secretion of digestive substances. [26] Noradrenaline and ATP are sympathetic co-transmitters.